Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

Journal of Oncology - United States
doi 10.1155/2009/937305
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Hindawi Limited

Related search

Targeted Approach to Metastatic Colorectal Cancer: What Comes Beyond Epidermal Growth Factor Receptor Antibodies and Bevacizumab?

Therapeutic Advances in Medical Oncology
Oncology
2012English

Treatment of Pancreatic Cancer With Epidermal Growth Factor Receptor-Targeted Therapy

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2009English

Dual Epidermal Growth Factor Inhibition and Multi Targeted Epigenetic Therapy (MTET)

Journal of Cancer Therapy
2018English

Human Epidermal Growth Factor Receptor 2-Targeted Therapies in Breast Cancer

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2013English

Expression of Growth Factor Receptor Family Before and After Targeted Therapy in Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Tissues

Korean Journal of Clinical Oncology
2015English

The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy

Clinical Cancer Research
Cancer ResearchOncology
2006English

Vascular Endothelial Growth Factor Receptor-1 Modulates Vascular Endothelial Growth Factor-Mediated Angiogenesis via Nitric Oxide

American Journal of Pathology
Forensic MedicinePathology
2001English

Laparoscopic Colorectal Surgery and Vascular Endothelial Growth Factor

Surgical Endoscopy
Surgery
2007English

Serum Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-1 Levels in Patients With Fibromyalgia Syndrome

Archives of Rheumatology
Rheumatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy